Drotrecogin alfa (activated) in severe sepsis: a systematic review and new cost-effectiveness analysis
-
* Corresponding author: James M Brophy james.brophy@mcgill.ca
BMC Anesthesiology 2007, 7:5 doi:10.1186/1471-2253-7-5
Pre-publication versions of this article and reviewers' reports
| Resubmission - Version 2 | Manuscript | 12 Mar 2007 | |
| Reviewer's Report | Christian Wiedermann | 26 Mar 2007 | |
| Reviewer's Report | Peter Eichacker | 30 Mar 2007 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 26 Apr 2007 |
| Reviewer's Report | Peter Eichacker | 16 May 2007 | |
| Editorial acceptance | 31 May 2007 | ||
| Published | 25 Jun 2007 |